How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-venous-thromboembolism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of venous thromboembolism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of venous thromboembolism (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of venous thromboembolism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Lovenox (Preservative Free)	ENOXAPARIN SODIUM	Sanofi	Low Molecular Weight Heparin	Antithrombin-III	1993-01-01
Lovenox	Lovenox	University of Monastir		Antithrombin-III
Enoxaparin	Enoxaparin	Dana-Farber Cancer Institute		Antithrombin-III

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Dana-Farber Cancer Institute · 1 drug in Prevention of venous thromboembolism
Sanofi · 1 drug in Prevention of venous thromboembolism
University of Monastir · 1 drug in Prevention of venous thromboembolism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of venous thromboembolism:

Cite this brief

Drug Landscape (2026). Prevention of venous thromboembolism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-venous-thromboembolism. Accessed 2026-06-10.

Prevention of venous thromboembolism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing